Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|August 9, 2020
Annulation reaction enables the identification of an exocyclic amide tricyclic chemotype as retinoic acid Receptor-Related orphan receptor gamma (RORγ/RORc) inverse agonistsDavid Marcoux, Myra Beaudoin Bertrand, Carolyn A Weigelt, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Identification of novel and potent isoquinoline aminooxazole-based IMPDH inhibitorsPing Chen, Derek Norris, Kristin D Haslow, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2020
Discovery of 2,6-difluorobenzyl ether series of phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonistsJames J-W Duan, Bin Jiang, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Quinolone-based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analoguesT G Murali Dhar, Scott H Watterson, Ping Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2007
Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffoldsT G Murali Dhar, Stephen T Wrobleski, Shuqun Lin, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Novel inhibitors of IMPDH: a highly potent and selective quinolone-based seriesScott H Watterson, Marianne Carlsen, T G Murali Dhar, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2002
Rapid synthesis of triazine inhibitors of inosine monophosphate dehydrogenaseWilliam J Pitts, Junqing Guo, T G Murali Dhar, et al.
Nature|October 3, 2023
Complex molecule synthesis by electrocatalytic decarboxylative cross-couplingBenxiang Zhang, Jiayan He, Yang Gao, et al.
European Journal of Pharmacology|December 8, 2000
In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha1A-adrenoceptor antagonistR S Chang, T B Chen, S S O'Malley, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffoldDominique Potin, Michele Launay, Eric Nicolai, et al.
Pageof 10